Skip to content

Comparison of the effect of endotracheal suction using two methods, endotracheal N-acetylcysteine and normal saline, on hemodynamic parameters and arterial blood gases in intubated patients under mechanical

Comparison of the effect of endotracheal suction using two methods, endotracheal N-acetylcysteine and normal saline, on hemodynamic parameters and arterial blood gases in intubated patients under mechanical

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231104059949N1
Enrollment
90
Registered
2023-12-14
Start date
2023-12-11
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients should be intubated and under mechanical ventilation.. Dependence on respirator [ventilator] status

Interventions

Intervention 1: Intervention group: Endotracheal suction with N-acetylcysteine is such that 2 ml of 20% N-acetyl cysteine liquid solution is poured by the researcher into the patient s tracheal tube d

Sponsors

Zabol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients who are connected to mechanical ventilation for at least 48 hours and at most one week Patients with endotracheal tubes Patients who are between 20 and 60 years old Patients who are hemodynamically stable (heart rate between 60-100 beats per minute, blood pressure between 160/100-110/60 mmHg, Spo2 more than 90%, urinary output more than 30 ml/hour) Patients with normal electrolyte levels and no cardiac arrhythmia Insensitivity to N-acetylcysteine and other drugs Absence of pulmonary edema, chronic obstructive pulmonary diseases and asthma Patients who do not have chest trauma or chest tube Absence of brain edema, spinal cord injury, increased intracranial pressure

Exclusion criteria

Exclusion criteria: Patients who are hemodynamically unstable (heart rate less than 60 beats per minute, blood pressure less than 100/60 mmHg, Spo2 less than 90%) Any changes in mechanical ventilation settings during the study Death of the patient Lack of consent of the patient's family Use of muscle relaxants and inotropic drugs during the study

Design outcomes

Primary

MeasureTime frame
Arterial oxygen saturation, which is considered as a hemodynamic parameter. Timepoint: The Arterial oxygen saturation is measured at the beginning of the study (before the intervention) and 1, 5 and 30 minutes after the intervention. Method of measurement: It is controlled and recorded by means of monitoring connected to the patient.;Respiratory rate, which is considered as a hemodynamic parameter. Timepoint: The Respiratory rate is measured at the beginning of the study (before the intervention) and 1, 5 and 30 minutes after the intervention. Method of measurement: For 1 minute, the Respiratory rate is counted and recorded in the patient's chest by observation method.;Arterial blood gases include PH, PCO2, PO2, HCO3, SPO2. Timepoint: Arterial blood gases are measured at the beginning of the study (5 minutes before the intervention) and 25 minutes after the intervention. Method of measurement: Blood gas Technomedica Arterial Blood Gas Analyzer Gastat-720 series.;Heart rate, which is considered as a hemodynamic parameter. Timepoint: The heart rate is measured at the beginning of the study (before the intervention) and 1, 5 and 30 minutes after the intervention. Method of measurement: It is controlled and recorded by means of monitoring connected to the patient.;Blood pressure, which is considered as a hemodynamic parameter. Timepoint: The blood pressure is measured at the beginning of the study (before the intervention) and 1, 5 and 30 minutes after the intervention. Method of measurement: It is controlled and recorded by means of monitoring connected to the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Absalan

Zabol University of Medical Sciences

ahmadabsalan0@gmail.com+98 54 3223 0469

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026